| Original language | English (US) |
|---|---|
| Pages (from-to) | 14-16 |
| Number of pages | 3 |
| Journal | Annals of Allergy, Asthma and Immunology |
| Volume | 125 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 2020 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pulmonary and Respiratory Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Annals of Allergy, Asthma and Immunology, Vol. 125, No. 1, 07.2020, p. 14-16.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Managing food protein–induced enterocolitis syndrome during the coronavirus disease 2019 pandemic
T2 - Expert recommendations
AU - Medical Advisory Board of the International FPIES Association
AU - Nowak-Wegrzyn, Anna
AU - Cianferoni, Antonella
AU - Bird, J. A.
AU - Fiocchi, Alessandro
AU - Caubet, Jean Christoph
AU - Arasi, Stefania
AU - Barad, Ashis V.
AU - Bingemann, Theresa
AU - Brown-Whitehorn, Terri
AU - Durban, Raquel
AU - Green, Todd
AU - Konstantinou, George
AU - Leonard, Stephanie
AU - Lightdale, Jennifer
AU - Muraro, Antonella
AU - Nomura, Ichiro
AU - Spergel, Jonathan
AU - Venter, Carina
N1 - Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein–Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone , Sanofi , Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone , Stallergenes, Abbott , DBV , Novartis , Hipp, and International Food Protein–Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health–National Institute of Allergy and Infectious Diseases, Genentech , Food Allergy Research and Education , Aimmune Therapeutics, Astellas , and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education . The remaining authors have no conflicts of interest to report. Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein?Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone, Sanofi, Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone, Stallergenes, Abbott, DBV, Novartis, Hipp, and International Food Protein?Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health?National Institute of Allergy and Infectious Diseases, Genentech, Food Allergy Research and Education, Aimmune Therapeutics, Astellas, and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education. The remaining authors have no conflicts of interest to report.
PY - 2020/7
Y1 - 2020/7
UR - http://www.scopus.com/inward/record.url?scp=85084617067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084617067&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2020.04.032
DO - 10.1016/j.anai.2020.04.032
M3 - Article
C2 - 32387170
AN - SCOPUS:85084617067
SN - 1081-1206
VL - 125
SP - 14
EP - 16
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 1
ER -